Q3 2025 Bausch + Lomb Corp Earnings Call Transcript
Key Points
- Bausch & Lomb Corp (BLCO) reported a 6% year-over-year revenue growth on a constant currency basis, driven by strong performance across all segments.
- The pharmaceutical segment was a standout, with MIEBO generating $84 million in revenue, marking a 71% increase year over year.
- Vision Care revenue increased by 6%, with significant growth in contact lenses and consumer offerings.
- The company has a robust pipeline of innovative products, with anticipated launches over the next several years, which are expected to drive future growth.
- BLCO's adjusted EBITDA grew by 7% year over year, reflecting strong operational performance and effective cost management.
- Adjusted gross margin decreased by 130 basis points year over year, primarily due to product mix and the impact of the Invista recall.
- The contact lens market is experiencing some softness, particularly in Southeast Asia and China, which could impact future growth.
- The company is facing challenges related to tariffs, which remain a fluid situation and could impact financial performance if not mitigated.
- Despite strong revenue growth, the company is still in the process of recovering from the Invista recall, which has affected the surgical segment.
- BLCO's adjusted R&D expenses increased by 13% over the previous year, which could pressure margins if not offset by revenue growth.
Good morning and welcome to Bausch + Lomb's third quarter 2025 earnings call. (Operator Instructions) I would now like to turn the conference over to George Gadkowski, Vice President of Investor Relations and Business Insights. Please go ahead.
+-
Thank you. Good morning, everyone, and welcome to our third quarter 2025 financial results conference call. Participating on today's call our Chairman and Chief Executive Officer, Mr. Brent Saunders and; Chief Financial Officer, Mr. Sam Eldessouky. In addition to this live webcast, a copy of today's live presentation and a replay of this conference call will be available on our website under the Investor Relations section.
Before we begin, I would like to remind you that our presentation today contains forward-looking information. We would ask that you take a moment to read the forward-looking legend at the beginning of our presentation, as it contains important information.
This presentation contains non-GAAP
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
